US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tharimmune Inc.

2.98

-0.1800-5.70%

Post-market: 2.95-0.0300-1.01%19:40 EDT

Volume:638.40K

Turnover:2.08M

Market Cap:20.29M

PE:-0.32

High:3.52

Open:3.22

Low:2.95

Close:3.16

52wk High:9.08

52wk Low:0.9520

Shares:6.81M

Float Shares:5.64M

Volume Ratio:2.25

T/O Rate:11.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.4096

EPS(LYR):-9.4096

ROE:-340.26%

ROA:-140.33%

PB:55.24

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Tharimmune Inc - Increases Authorized Common Stock to 1 Bln Shares - SEC Filing

THOMSON REUTERS

Tharimmune Inc increases authorized common stock to 1 billion shares

Tharimmune Inc held special meeting of stockholders

Tharimmune Inc. Announces Date for 2025 Special Stockholders Meeting

Tharimmune Inc. Boosts Executive Compensation with Significant Salary Increases and Enhanced Change of Control Benefits

Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director Nancy Davis Rickel

BRIEF-Tharimmune Inc Enters $5.35 Mln Securities Purchase Agreement - SEC Filing

Tharimmune Shares Drop After Securities Purchase Agreement

Tharimmune (THAR) Stock Is Surging Monday: What's Going On?

Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director James Gordon Liddy

Tharimmune (THAR) Shares Skyrocket On Promising Opioid Countermeasure Data

Benzinga_recent_news

Top Premarket Gainers

MT Newswires Live

Premarket Movers | AMD, Nvidia, and SMCI Tick Higher; CoreWeave Jumps Nearly 2%; NuScale Power, Oklo up about 3%;Tharimmune Rockets 51%

Tiger Newspress

Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director Gary S. Stetz

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live

Tharimmune Inc. Announces Positive Pharmacokinetic Simulation Results for TH104, Highlighting Its Potential Superiority as Prophylaxis Against Fentanyl-Induced Respiratory Depression

Tharimmune Q2 EPS $(0.64) Up From $(2.42) YoY

Tharimmune Inc. Secures Key Global Patent Allowances for TH-104, Strengthening Strategy Against Weaponized Opioids

Tharimmune Inc. Appoints Visionary Philanthropist Nancy Davis to Board of Directors

Tharimmune Inc. Appoints Philanthropist and Advocate Nancy Davis to Board of Directors, Enhancing Focus on Innovative Therapeutic Solutions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/THAR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"THAR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THAR\",,,,,undefined,":{"symbol":"THAR","market":"US","secType":"STK","nameCN":"Tharimmune Inc.","latestPrice":2.98,"timestamp":1760126400000,"preClose":3.16,"halted":0,"volume":638398,"hourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.98,"latestTime":"19:40 EDT","volume":53780,"amount":154459.5816,"timestamp":1760139640616},"delay":0,"floatShares":5642500,"shares":6809200,"eps":-9.409598,"marketStatus":"Not Yet Opened","change":-0.18,"latestTime":"10-10 16:00:00 EDT","open":3.22,"high":3.52,"low":2.95,"amount":2082509.4335871998,"amplitude":0.18038,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.409598,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760342400000},"marketStatusCode":0,"adr":0,"listingDate":1641963600000,"exchange":"NASDAQ","adjPreClose":3.16,"preHourTrading":{"tag":"盘前","latestPrice":3.26,"preClose":3.16,"latestTime":"09:29 EDT","volume":10957,"amount":35259.823226,"timestamp":1760102956794},"postHourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.98,"latestTime":"19:40 EDT","volume":53780,"amount":154459.5816,"timestamp":1760139640616},"volumeRatio":2.2496824141642744},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THAR\",,,,,undefined,":{"symbol":"THAR","floatShares":5642500,"roa":"-140.33%","roe":"-340.26%","lyrEps":-9.409598,"volumeRatio":2.2496824141642744,"shares":6809200,"dividePrice":0,"high":3.52,"amplitude":0.18038,"preClose":3.16,"low":2.95,"week52Low":0.952,"pbRate":"55.24","week52High":9.08,"institutionHeld":0,"latestPrice":2.98,"eps":-9.409598,"divideRate":0,"volume":638398,"delay":0,"ttmEps":-9.409598,"open":3.22,"prevYearClose":2.03,"prevWeekClose":2.91,"prevMonthClose":2.84,"prevQuarterClose":2.84,"fiveDayClose":2.91,"twentyDayClose":3.14,"sixtyDayClose":1.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THAR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"THAR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2025-03-25","symbol":"THAR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-2.02},{"market":"US","date":"2024-08-09","symbol":"THAR","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"","actualEps":-2.42},{"market":"US","date":"2024-05-28","symbol":"THAR","defaultRemindTime":1716903000000,"type":"split","dateTimestamp":1716868800000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-05-09","symbol":"THAR","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THAR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THAR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/THAR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"THAR","date":"2025-10-10","current":-0.316698,"percent":0.021053,"low":-2.974862,"twenty":-0.477558,"median":-0.333715,"eighty":-0.256627,"high":-0.078899,"avg":-0.425845,"sd":0.361029,"marketCap":18634441},"quantilePoints":[{"date":"2023-09-29","current":-0.382876,"twenty":-0.507054,"median":-0.396691,"eighty":-0.388402,"marketCap":3414917},{"date":"2023-10-05","current":-0.371034,"twenty":-0.396296,"median":-0.39077,"eighty":-0.38406,"marketCap":3309301},{"date":"2023-10-10","current":-0.365113,"twenty":-0.395507,"median":-0.388797,"eighty":-0.373639,"marketCap":3256493},{"date":"2023-10-19","current":-0.400638,"twenty":-0.396296,"median":-0.385837,"eighty":-0.371823,"marketCap":3573340},{"date":"2023-10-27","current":-0.354061,"twenty":-0.395901,"median":-0.382876,"eighty":-0.367481,"marketCap":3157918},{"date":"2023-11-02","current":-0.314984,"twenty":-0.394717,"median":-0.375178,"eighty":-0.354061,"marketCap":2809385},{"date":"2023-11-10","current":-0.37416,"twenty":-0.396691,"median":-0.374981,"eighty":-0.345575,"marketCap":3222178},{"date":"2023-11-17","current":-0.366027,"twenty":-0.394717,"median":-0.374571,"eighty":-0.354061,"marketCap":3152131},{"date":"2023-11-24","current":-0.23385,"twenty":-0.395112,"median":-0.373042,"eighty":-0.340009,"marketCap":2013859},{"date":"2023-12-01","current":-0.246337,"twenty":-0.391559,"median":-0.36684,"eighty":-0.303758,"marketCap":2121398},{"date":"2023-12-08","current":-0.177715,"twenty":-0.389586,"median":-0.365113,"eighty":-0.2671,"marketCap":1530437},{"date":"2023-12-15","current":-0.142524,"twenty":-0.386603,"median":-0.352622,"eighty":-0.21331,"marketCap":1227380},{"date":"2023-12-22","current":-0.155427,"twenty":-0.384688,"median":-0.345575,"eighty":-0.188612,"marketCap":1338501},{"date":"2023-12-29","current":-0.146629,"twenty":-0.383782,"median":-0.317747,"eighty":-0.176783,"marketCap":1262737},{"date":"2024-01-05","current":-0.146659,"twenty":-0.38276,"median":-0.312306,"eighty":-0.157175,"marketCap":1262989},{"date":"2024-01-12","current":-0.139005,"twenty":-0.38091,"median":-0.292008,"eighty":-0.148917,"marketCap":1197074},{"date":"2024-01-19","current":-0.114078,"twenty":-0.375376,"median":-0.280942,"eighty":-0.146629,"marketCap":982409},{"date":"2024-01-26","current":-0.133403,"twenty":-0.374981,"median":-0.23385,"eighty":-0.14311,"marketCap":1148838},{"date":"2024-02-02","current":-0.127861,"twenty":-0.37416,"median":-0.20534,"eighty":-0.138301,"marketCap":1101106},{"date":"2024-02-09","current":-0.111585,"twenty":-0.371924,"median":-0.18314,"eighty":-0.129796,"marketCap":960942},{"date":"2024-02-16","current":-0.114019,"twenty":-0.371034,"median":-0.158301,"eighty":-0.127861,"marketCap":981904},{"date":"2024-02-23","current":-0.111145,"twenty":-0.367679,"median":-0.155427,"eighty":-0.121656,"marketCap":957154},{"date":"2024-03-01","current":-0.48475,"twenty":-0.37506,"median":-0.166843,"eighty":-0.12223,"marketCap":4517427},{"date":"2024-03-08","current":-0.465853,"twenty":-0.385872,"median":-0.188565,"eighty":-0.123227,"marketCap":4341332},{"date":"2024-03-15","current":-0.464846,"twenty":-0.39748,"median":-0.211982,"eighty":-0.126981,"marketCap":4331940},{"date":"2024-03-22","current":-0.557437,"twenty":-0.450736,"median":-0.23385,"eighty":-0.128799,"marketCap":5194806},{"date":"2024-03-28","current":-0.547624,"twenty":-0.468827,"median":-0.280942,"eighty":-0.129034,"marketCap":5103356},{"date":"2024-04-05","current":-0.579242,"twenty":-0.47694,"median":-0.299351,"eighty":-0.129034,"marketCap":5398007},{"date":"2024-04-12","current":-0.522329,"twenty":-0.488151,"median":-0.314984,"eighty":-0.129491,"marketCap":4867635},{"date":"2024-04-19","current":-0.477811,"twenty":-0.486603,"median":-0.348379,"eighty":-0.13196,"marketCap":4452767},{"date":"2024-04-26","current":-0.45669,"twenty":-0.485414,"median":-0.359587,"eighty":-0.135532,"marketCap":4255940},{"date":"2024-05-03","current":-0.477432,"twenty":-0.482784,"median":-0.366433,"eighty":-0.137304,"marketCap":4449231},{"date":"2024-05-10","current":-0.518662,"twenty":-0.485414,"median":-0.371924,"eighty":-0.137996,"marketCap":4833456},{"date":"2024-05-17","current":-0.488448,"twenty":-0.487514,"median":-0.375178,"eighty":-0.138723,"marketCap":4340799},{"date":"2024-05-24","current":-0.434206,"twenty":-0.489085,"median":-0.382876,"eighty":-0.14006,"marketCap":3858750},{"date":"2024-05-31","current":-0.396974,"twenty":-0.487825,"median":-0.388797,"eighty":-0.141468,"marketCap":3527876},{"date":"2024-06-07","current":-0.451939,"twenty":-0.486699,"median":-0.395704,"eighty":-0.142758,"marketCap":4016347},{"date":"2024-06-14","current":-0.295417,"twenty":-0.486079,"median":-0.392744,"eighty":-0.143233,"marketCap":2625343},{"date":"2024-06-21","current":-0.276843,"twenty":-0.48475,"median":-0.386969,"eighty":-0.143726,"marketCap":2460277},{"date":"2024-06-28","current":-0.285687,"twenty":-0.484266,"median":-0.384008,"eighty":-0.144206,"marketCap":2538880},{"date":"2024-07-05","current":-0.293648,"twenty":-0.483128,"median":-0.378835,"eighty":-0.145162,"marketCap":2609622},{"date":"2024-07-12","current":-0.336103,"twenty":-0.481172,"median":-0.37416,"eighty":-0.146207,"marketCap":2986917},{"date":"2024-07-15","current":-0.339198,"twenty":-0.48087,"median":-0.373042,"eighty":-0.146313,"marketCap":3014428},{"date":"2024-08-02","current":-0.39802,"twenty":-0.480567,"median":-0.37416,"eighty":-0.146418,"marketCap":3537173},{"date":"2024-08-09","current":-0.357356,"twenty":-0.479583,"median":-0.371479,"eighty":-0.146647,"marketCap":3175790},{"date":"2024-08-16","current":-0.388311,"twenty":-0.47931,"median":-0.367704,"eighty":-0.147503,"marketCap":3446280},{"date":"2024-08-23","current":-0.383133,"twenty":-0.478979,"median":-0.3683,"eighty":-0.148084,"marketCap":3400329},{"date":"2024-08-30","current":-0.3621,"twenty":-0.478193,"median":-0.368895,"eighty":-0.150559,"marketCap":3213656},{"date":"2024-09-06","current":-0.374966,"twenty":-0.47771,"median":-0.368895,"eighty":-0.152319,"marketCap":3327842},{"date":"2024-09-13","current":-0.387016,"twenty":-0.477508,"median":-0.371479,"eighty":-0.153668,"marketCap":3434792},{"date":"2024-09-20","current":-0.387573,"twenty":-0.477179,"median":-0.37416,"eighty":-0.156013,"marketCap":3439732},{"date":"2024-09-27","current":-0.318415,"twenty":-0.476049,"median":-0.370611,"eighty":-0.157456,"marketCap":2825949},{"date":"2024-10-04","current":-0.288644,"twenty":-0.474874,"median":-0.368895,"eighty":-0.165134,"marketCap":2561734},{"date":"2024-10-11","current":-0.263637,"twenty":-0.474587,"median":-0.367652,"eighty":-0.176316,"marketCap":2339794},{"date":"2024-10-18","current":-0.304177,"twenty":-0.472752,"median":-0.367031,"eighty":-0.182055,"marketCap":2699586},{"date":"2024-10-25","current":-0.259599,"twenty":-0.469988,"median":-0.36557,"eighty":-0.188659,"marketCap":2303953},{"date":"2024-10-31","current":-0.443968,"twenty":-0.46923,"median":-0.363606,"eighty":-0.192108,"marketCap":3940246},{"date":"2024-11-08","current":-0.314532,"twenty":-0.469028,"median":-0.3621,"eighty":-0.207997,"marketCap":2791486},{"date":"2024-11-15","current":-0.305403,"twenty":-0.46859,"median":-0.361023,"eighty":-0.220423,"marketCap":3313862},{"date":"2024-11-22","current":-0.357444,"twenty":-0.468401,"median":-0.359587,"eighty":-0.228864,"marketCap":3878556},{"date":"2024-11-29","current":-0.28486,"twenty":-0.468199,"median":-0.357833,"eighty":-0.23385,"marketCap":3090956},{"date":"2024-12-06","current":-0.278012,"twenty":-0.466808,"median":-0.355708,"eighty":-0.23385,"marketCap":3016655},{"date":"2024-12-13","current":-0.298555,"twenty":-0.465853,"median":-0.352068,"eighty":-0.239263,"marketCap":3239560},{"date":"2024-12-20","current":-0.287599,"twenty":-0.465417,"median":-0.349391,"eighty":-0.246337,"marketCap":3120677},{"date":"2024-12-27","current":-0.294447,"twenty":-0.465417,"median":-0.343978,"eighty":-0.247606,"marketCap":3194979},{"date":"2025-01-03","current":-0.280751,"twenty":-0.465265,"median":-0.340267,"eighty":-0.248902,"marketCap":3046375},{"date":"2025-01-10","current":-0.297186,"twenty":-0.465036,"median":-0.335817,"eighty":-0.250096,"marketCap":3224700},{"date":"2025-01-17","current":-0.273904,"twenty":-0.46288,"median":-0.332711,"eighty":-0.251506,"marketCap":2972074},{"date":"2025-01-24","current":-0.295816,"twenty":-0.459788,"median":-0.324576,"eighty":-0.253179,"marketCap":3209839},{"date":"2025-01-31","current":-0.271165,"twenty":-0.458942,"median":-0.322298,"eighty":-0.256285,"marketCap":2942353},{"date":"2025-02-07","current":-0.367119,"twenty":-0.457712,"median":-0.324576,"eighty":-0.25649,"marketCap":3983531},{"date":"2025-02-14","current":-0.338605,"twenty":-0.457135,"median":-0.332752,"eighty":-0.257766,"marketCap":3674130},{"date":"2025-02-21","current":-0.332011,"twenty":-0.45669,"median":-0.334163,"eighty":-0.259599,"marketCap":3602581},{"date":"2025-02-28","current":-0.258409,"twenty":-0.45669,"median":-0.332711,"eighty":-0.258409,"marketCap":2803941},{"date":"2025-03-07","current":-0.279794,"twenty":-0.452773,"median":-0.327411,"eighty":-0.258409,"marketCap":3035992},{"date":"2025-03-14","current":-0.258409,"twenty":-0.451939,"median":-0.323592,"eighty":-0.257308,"marketCap":2803941},{"date":"2025-03-21","current":-0.27623,"twenty":-0.447209,"median":-0.318081,"eighty":-0.256285,"marketCap":2997317},{"date":"2025-03-28","current":-0.235121,"twenty":-0.446876,"median":-0.316359,"eighty":-0.256285,"marketCap":2867904},{"date":"2025-04-04","current":-0.216104,"twenty":-0.443968,"median":-0.314758,"eighty":-0.253062,"marketCap":2635941},{"date":"2025-04-11","current":-0.183256,"twenty":-0.434206,"median":-0.310649,"eighty":-0.250909,"marketCap":2235278},{"date":"2025-04-17","current":-0.190171,"twenty":-0.43272,"median":-0.309629,"eighty":-0.247606,"marketCap":2319628},{"date":"2025-04-25","current":-0.208324,"twenty":-0.428819,"median":-0.307528,"eighty":-0.235121,"marketCap":2541047},{"date":"2025-05-02","current":-0.267969,"twenty":-0.427212,"median":-0.306444,"eighty":-0.235121,"marketCap":3268567},{"date":"2025-05-09","current":-0.257596,"twenty":-0.421057,"median":-0.305275,"eighty":-0.235121,"marketCap":3142041},{"date":"2025-05-16","current":-0.223829,"twenty":-0.40927,"median":-0.304177,"eighty":-0.235121,"marketCap":2794097},{"date":"2025-05-23","current":-0.292009,"twenty":-0.404831,"median":-0.304105,"eighty":-0.236223,"marketCap":3645195},{"date":"2025-05-30","current":-0.315455,"twenty":-0.404174,"median":-0.304105,"eighty":-0.238157,"marketCap":3937875},{"date":"2025-06-06","current":-0.321849,"twenty":-0.402002,"median":-0.304798,"eighty":-0.241659,"marketCap":4017697},{"date":"2025-06-13","current":-0.292009,"twenty":-0.399067,"median":-0.305275,"eighty":-0.243561,"marketCap":3645195},{"date":"2025-06-20","current":-0.304798,"twenty":-0.397602,"median":-0.304972,"eighty":-0.244794,"marketCap":3804839},{"date":"2025-06-27","current":-0.375157,"twenty":-0.396861,"median":-0.305146,"eighty":-0.246971,"marketCap":4683145},{"date":"2025-07-03","current":-0.39645,"twenty":-0.396917,"median":-0.305471,"eighty":-0.248249,"marketCap":4948952},{"date":"2025-07-11","current":-0.5972,"twenty":-0.404301,"median":-0.306569,"eighty":-0.249668,"marketCap":7454942},{"date":"2025-07-18","current":-0.556712,"twenty":-0.425538,"median":-0.306929,"eighty":-0.250279,"marketCap":6949522},{"date":"2025-07-25","current":-0.516223,"twenty":-0.442016,"median":-0.309442,"eighty":-0.250983,"marketCap":6444102},{"date":"2025-08-01","current":-0.420971,"twenty":-0.447142,"median":-0.310453,"eighty":-0.25128,"marketCap":5255045},{"date":"2025-08-08","current":-0.426043,"twenty":-0.447142,"median":-0.313377,"eighty":-0.251504,"marketCap":5318359},{"date":"2025-08-15","current":-0.44633,"twenty":-0.447142,"median":-0.314989,"eighty":-0.252534,"marketCap":5571614},{"date":"2025-08-22","current":-1.917648,"twenty":-0.452606,"median":-0.315455,"eighty":-0.253419,"marketCap":23037197},{"date":"2025-08-29","current":-2.33436,"twenty":-0.457135,"median":-0.31712,"eighty":-0.254845,"marketCap":28043268},{"date":"2025-09-05","current":-1.53952,"twenty":-0.45993,"median":-0.318415,"eighty":-0.254845,"marketCap":18494651},{"date":"2025-09-12","current":-1.434614,"twenty":-0.465417,"median":-0.321839,"eighty":-0.255867,"marketCap":17234390},{"date":"2025-09-19","current":-1.219193,"twenty":-0.468452,"median":-0.32372,"eighty":-0.256285,"marketCap":14646478},{"date":"2025-09-26","current":-1.333779,"twenty":-0.470476,"median":-0.328904,"eighty":-0.256285,"marketCap":16023027},{"date":"2025-10-03","current":-1.397947,"twenty":-0.474798,"median":-0.332549,"eighty":-0.256627,"marketCap":16793894},{"date":"2025-10-10","current":-1.551156,"twenty":-0.477558,"median":-0.333715,"eighty":-0.256627,"marketCap":18634441}],"updateTime":1760310761224},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THAR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574107575","title":"Tharimmune Inc - Increases Authorized Common Stock to 1 Bln Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107575?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:23","pubTimestamp":1760127839,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR1JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2574107520","title":"Tharimmune Inc increases authorized common stock to 1 billion shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107520","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107520?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:22","pubTimestamp":1760127769,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has amended its Certificate of Incorporation to increase the total number of authorized shares of Common Stock from 250,000,000 to 1,000,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL5Cz2Nq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2574191384","title":"Tharimmune Inc held special meeting of stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2574191384","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574191384?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:15","pubTimestamp":1760040955,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. held a special meeting of stockholders on October 9, 2025. Stockholders approved a proposal granting the board of directors authority to increase the total number of shares of common stock. An amendment to the Omnibus Equity Incentive Plan to increase the number of shares reserved for issuance was also approved. In addition, stockholders approved the issuance of securities in one or more non-public offerings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 09, 2025, and is solely responsible for the inf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL55cPK3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2566263232","title":"Tharimmune Inc. Announces Date for 2025 Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2566263232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566263232?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:21","pubTimestamp":1757362880,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has scheduled a special meeting of stockholders to be held in Red Bank, NJ, in October 2025. During the meeting, stockholders will consider a proposal to give the board of directors the authority to file an amendment to the company's certificate of incorporation. This amendment aims to increase the total number of shares of Common Stock authorized for issuance from the current limit of 250,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 08, 2025, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL8bRgfr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2566340206","title":"Tharimmune Inc. Boosts Executive Compensation with Significant Salary Increases and Enhanced Change of Control Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2566340206","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566340206?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:16","pubTimestamp":1757362597,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has announced updates to the compensation terms for its top executives. Effective September 2, 2025, the Compensation Committee of the company's Board of Directors approved a $100,000 increase in the base salaries of CEO Sireesh Appajosyula and Executive Chairman Vincent LoPriore, bringing their annual salaries to $385,000. Additionally, the committee has enhanced the severance package for both executives in the event of termination within a year following a change of control. The revised package increases the severance payment from two to three times their base salary and target bonus.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL4ywGRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2563936074","title":"Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director Nancy Davis Rickel","url":"https://stock-news.laohu8.com/highlight/detail?id=2563936074","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563936074?lang=en_us&edition=fundamental","pubTime":"2025-08-30 04:31","pubTimestamp":1756499461,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has filed an initial statement of beneficial ownership with the SEC. The filing identifies Nancy Davis Rickel as the beneficial owner, who holds the role of Director at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL5VTH2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2562755292","title":"BRIEF-Tharimmune Inc Enters $5.35 Mln Securities Purchase Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2562755292","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562755292?lang=en_us&edition=fundamental","pubTime":"2025-08-27 01:05","pubTimestamp":1756227900,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Inc Enters $5.35 Mln Securities Purchase Agreement - SEC FilingAug 26  - Tharimmune Inc THAR.O:THARIMMUNE INC - ENTERS $5.35 MILLION SECURITIES PURCHASE AGREEMENT - SEC FILINGSource text: [ID:n0001641172-25-025476]Further company coverage: THAR.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UI0S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2562753082","title":"Tharimmune Shares Drop After Securities Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2562753082","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562753082?lang=en_us&edition=fundamental","pubTime":"2025-08-27 00:26","pubTimestamp":1756225560,"startTime":"0","endTime":"0","summary":"Tharimmune  shares were 16% lower, at $6.50, after the company entered into a securities purchase agreement worth $5.35 million with certain purchasers.In a filing with the Securities and Exchange Commission, the company said the agreement is for $5.35 million of its securities, consisting of 1.2 million shares at $4.50 a share.The stock hit its 52-week high of $9.08 Monday, and is up 129% in the past 12 months.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":1},{"id":"2562221784","title":"Tharimmune (THAR) Stock Is Surging Monday: What's Going On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2562221784","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562221784?lang=en_us&edition=fundamental","pubTime":"2025-08-26 02:06","pubTimestamp":1756145160,"startTime":"0","endTime":"0","summary":"Shares of Tharimmune are surging in Monday afternoon trading. The company last week announced promising simulation results for its lead clinical asset, TH104.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/25/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/25/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/25/08/47316377/tharimmune-thar-stock-is-surging-monday-whats-going-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/08/47316377/tharimmune-thar-stock-is-surging-monday-whats-going-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["THAR","BK4139"],"gpt_icon":1},{"id":"2561133400","title":"Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director James Gordon Liddy","url":"https://stock-news.laohu8.com/highlight/detail?id=2561133400","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561133400?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:16","pubTimestamp":1755893775,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has filed an initial statement of beneficial ownership. The filing reveals that James Gordon Liddy is a beneficial owner in the capacity of a Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL4KMVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":1},{"id":"2561130544","title":"Tharimmune (THAR) Shares Skyrocket On Promising Opioid Countermeasure Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2561130544","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561130544?lang=en_us&edition=fundamental","pubTime":"2025-08-22 03:28","pubTimestamp":1755804480,"startTime":"0","endTime":"0","summary":"Shares of Tharimmune are surging Thursday afternoon. The company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/21/Doctor-holding-digital-tablet-at-meeting.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/21/Doctor-holding-digital-tablet-at-meeting.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/08/47269004/tharimmune-thar-shares-skyrocket-on-promising-opioid-countermeasure-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/08/47269004/tharimmune-thar-shares-skyrocket-on-promising-opioid-countermeasure-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["THAR","BK4139"],"gpt_icon":1},{"id":"2561629804","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2561629804","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561629804?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:45","pubTimestamp":1755776705,"startTime":"0","endTime":"0","summary":"Tharimmune  shares were nearly 35% higher pre-bell Thursday, extending Wednesday's rally.Evoke Pharma  stock was up 30% after the company said its US patent for its gastroparesis nasal spray has been listed in the US Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations.Cato  shares were up 14% after the company reported higher fiscal Q2 earnings and revenue year over year.Fundamental Global  stock was up 9.2%, following a 0.1% gain in the previous session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","EVOK","THAR","BK4139","FGNX","BK4094","BK4007","CATO"],"gpt_icon":0},{"id":"1150896604","title":"Premarket Movers | AMD, Nvidia, and SMCI Tick Higher; CoreWeave Jumps Nearly 2%; NuScale Power, Oklo up about 3%;Tharimmune Rockets 51%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150896604","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150896604?lang=en_us&edition=fundamental","pubTime":"2025-08-21 16:17","pubTimestamp":1755764267,"startTime":"0","endTime":"0","summary":"$Tharimmune Inc.(THAR)$ jumped 51% in premarket trading after surging 207% in prior trading session following positive pharmacokinetic simulation results for its lead drug candidate TH104, designed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ba615c9de96d41e42004d4c7c26fdfd0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMD","OKLO","THAR","SMR","NVDA"],"gpt_icon":1},{"id":"2561025482","title":"Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director Gary S. Stetz","url":"https://stock-news.laohu8.com/highlight/detail?id=2561025482","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561025482?lang=en_us&edition=fundamental","pubTime":"2025-08-21 06:14","pubTimestamp":1755728083,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has filed an initial statement of beneficial ownership. The filing names Gary S. Stetz as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8Czsjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2561702483","title":"Sector Update: Health Care Stocks Rise in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2561702483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561702483?lang=en_us&edition=fundamental","pubTime":"2025-08-21 01:38","pubTimestamp":1755711537,"startTime":"0","endTime":"0","summary":"Health care stocks gained Wednesday afternoon, with the NYSE Health Care Index up 0.4% and the Health Care Select Sector SPDR Fund  adding 0.5%.The iShares Biotechnology ETF  increased 0.4%.In corporate news, Trinity Biotech  shares jumped about 28% after it said Wednesday that it has received regulatory approval to begin offshore and outsourced manufacturing of its TrinScreen HIV rapid test.Tharimmune  shares surged 103% after it said Wednesday that results from an analysis of its lead drug candidate TH104 showed that it could potentially be used as a countermeasure for military personnel and chemical incident responders exposed to high-potency opioids, including weaponized fentanyl.CVS Health's  Caremark unit has been ordered to pay about $289.9 million in a whistleblower case involving Medicare fraud claims, according to a court ruling on Tuesday. CVS shares increased 0.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765489.SGD","IE0002270589.USD","BK4588","BK4550","BK4196","IE00B19Z3B42.SGD","BK4139","BK4082","IBB","IE00BKVL7J92.USD","CVS.AU","LU0006061336.USD","LU0061475181.USD","BK4581","TRIB","THAR","CVS","LU1059921491.USD","IE00BSNM7G36.USD","LU0070302665.USD","IE00BZ1G4Q59.USD","LU0162691827.USD","LU1571399168.USD","IE00B19Z3581.USD","LU0208291251.USD","IE00B7SZLL34.SGD","LU0072461881.USD","LU1699723380.USD","LU0211331839.USD","BK4504","BK4585","XLV"],"gpt_icon":0},{"id":"2560617103","title":"Tharimmune Inc. Announces Positive Pharmacokinetic Simulation Results for TH104, Highlighting Its Potential Superiority as Prophylaxis Against Fentanyl-Induced Respiratory Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2560617103","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560617103?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:00","pubTimestamp":1755691246,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. Announces Positive Pharmacokinetic Simulation Results for TH104, Highlighting Its Potential Superiority as Prophylaxis Against Fentanyl-Induced Respiratory Depression. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDLb9y2sR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2559950261","title":"Tharimmune Q2 EPS $(0.64) Up From $(2.42) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559950261","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559950261?lang=en_us&edition=fundamental","pubTime":"2025-08-14 21:52","pubTimestamp":1755179544,"startTime":"0","endTime":"0","summary":"Tharimmune (NASDAQ:THAR) reported quarterly losses of $(0.64) per share. This is a 73.55 percent increase over losses of $(2.42) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47123131/tharimmune-q2-eps-0-64-up-from-2-42-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR"],"gpt_icon":0},{"id":"2559185604","title":"Tharimmune Inc. Secures Key Global Patent Allowances for TH-104, Strengthening Strategy Against Weaponized Opioids","url":"https://stock-news.laohu8.com/highlight/detail?id=2559185604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559185604?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:12","pubTimestamp":1755087149,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. announced a significant expansion of its intellectual property portfolio for its novel transmucosal film, TH-104, with new patents granted in Japan and Mexico, and patent applications allowed in Australia and the United States. These advancements secure protection for TH-104 until at least 2040 in key global markets. The patents cover a novel method and device for the transmucosal administration of nalmefene, offering a potentially effective treatment as a medical countermeasure for military and first responders against high-potency opioids. The company's long-term strategy includes pursuing broader indications for TH-104, addressing other significant medical needs such as pruritus related to chronic liver and kidney diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL80M1rW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2557594547","title":"Tharimmune Inc. Appoints Visionary Philanthropist Nancy Davis to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2557594547","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557594547?lang=en_us&edition=fundamental","pubTime":"2025-08-08 05:22","pubTimestamp":1754601755,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has announced the appointment of Nancy Davis to its Board of Directors. Davis, a well-known philanthropist and founder of the Race to Erase MS and Cure Addiction Now foundations, joins the board to support the company's efforts in developing innovative therapies for inflammation, immunology, and critical unmet medical needs. Her experience in patient advocacy and scientific collaboration is expected to contribute to Tharimmune's mission, particularly in advancing their investigational product, TH104.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL6W0l1m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2557539991","title":"Tharimmune Inc. Appoints Philanthropist and Advocate Nancy Davis to Board of Directors, Enhancing Focus on Innovative Therapeutic Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2557539991","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557539991?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:00","pubTimestamp":1754395235,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. Appoints Philanthropist and Advocate Nancy Davis to Board of Directors, Enhancing Focus on Innovative Therapeutic Solutions. Tharimmune Inc., a clinical-stage biotechnology company, has appointed Nancy Davis to its Board of Directors. Davis is the founder of Race to Erase MS and Cure Addiction Now. Her appointment aligns with Tharimmune's focus on developing therapies for critical unmet medical needs, including their investigational product TH104, which targets the effects of weaponized fentanyl.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 05, 2025, and is solely responsible for the information contained the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDLb5BC5p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}